[Silencing the MRP1 gene using CRISPRi technology to enhance the sensitivity of A549/DDP cells to cisplatin]. | Zhongguo Ying Yong Sheng Li Xue Za Zhi;38(4): 322-325, 2022 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

[Silencing the MRP1 gene using CRISPRi technology to enhance the sensitivity of A549/DDP cells to cisplatin].

Meng, Ling-Xue; Sun, Xin-di; Zhang, Wei-Wei; Guo, Xu; Shen, Yang; Shao, Shu-Li.

Zhongguo Ying Yong Sheng Li Xue Za Zhi ; 38(4): 322-325, 2022 Jul.

Article in Zh | MEDLINE | ID: mdl-36414555

Subject(s)

Cisplatin; Multidrug Resistance-Associated Proteins; Humans; Cisplatin/pharmacology; A549 Cells; Multidrug Resistance-Associated Proteins/genetics; Technology

Key words

A549 / DDP cells; CRISPRi; Cisplatin; MRP1; cell culture

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Multidrug Resistance-Associated Proteins Type of study: Diagnostic_studies Limits: Humans Language: Zh Journal: Zhongguo Ying Yong Sheng Li Xue Za Zhi Journal subject: FISIOLOGIA Year: 2022 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Multidrug Resistance-Associated Proteins Type of study: Diagnostic_studies Limits: Humans Language: Zh Journal: Zhongguo Ying Yong Sheng Li Xue Za Zhi Journal subject: FISIOLOGIA Year: 2022 Document type: Article